| Andrew J Mueting, DO | |
|
2501 Pierce St, Sioux City, IA 51104-3725 | |
| (712) 294-5000 | |
| (712) 294-5091 |
| Full Name | Andrew J Mueting |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 2501 Pierce St, Sioux City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831451012 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4468 (Iowa) | Secondary |
| 207Q00000X | Family Medicine | 4468 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakes Regional Healthcare Home Care | Spirit lake, IA | Home health agency |
| Lakes Regional Healthcare Hospice | Spirit lake, IA | Hospice |
| St Croix Hospice, Llc | Spencer, IA | Hospice |
| Lakes Regional Healthcare | Spirit lake, IA | Hospital |
| Spencer Municipal Hospital | Spencer, IA | Hospital |
| Avera Holy Family Hospital | Estherville, IA | Hospital |
| Accura Healthcare Of Spirit Lake | Spirit lake, IA | Nursing home |
| Aspire Of Lake Park | Lake park, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakes Regional Healthcare | 0941118442 | 40 |
News Archive
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
A Tainan-based research team from National Cheng Kung University (NCKU) has discovered the pathogenesis of liver fibrosis and developed antibodies that reduce liver damage, inhibit hepatic fibrosis, and recover liver function.
Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. But a new diagnostic test developed by researchers at UC San Diego shows promise for detecting the disease earlier.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Emissary Capital Group, Inc. has initiated investment research coverage on Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) with a Buy rating and target price of $1.00-$1.25.
› Verified 2 days ago
| Entity Name | Lakes Regional Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336291160 PECOS PAC ID: 0941118442 Enrollment ID: O20031223000386 |
News Archive
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
A Tainan-based research team from National Cheng Kung University (NCKU) has discovered the pathogenesis of liver fibrosis and developed antibodies that reduce liver damage, inhibit hepatic fibrosis, and recover liver function.
Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. But a new diagnostic test developed by researchers at UC San Diego shows promise for detecting the disease earlier.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Emissary Capital Group, Inc. has initiated investment research coverage on Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) with a Buy rating and target price of $1.00-$1.25.
› Verified 2 days ago
| Entity Name | Siouxland Medical Education Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336127828 PECOS PAC ID: 6608761101 Enrollment ID: O20040216000191 |
News Archive
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
A Tainan-based research team from National Cheng Kung University (NCKU) has discovered the pathogenesis of liver fibrosis and developed antibodies that reduce liver damage, inhibit hepatic fibrosis, and recover liver function.
Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. But a new diagnostic test developed by researchers at UC San Diego shows promise for detecting the disease earlier.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Emissary Capital Group, Inc. has initiated investment research coverage on Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) with a Buy rating and target price of $1.00-$1.25.
› Verified 2 days ago
| Entity Name | Northwest Iowa Emergency Physicians, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871519207 PECOS PAC ID: 3971495797 Enrollment ID: O20040326000817 |
News Archive
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
A Tainan-based research team from National Cheng Kung University (NCKU) has discovered the pathogenesis of liver fibrosis and developed antibodies that reduce liver damage, inhibit hepatic fibrosis, and recover liver function.
Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. But a new diagnostic test developed by researchers at UC San Diego shows promise for detecting the disease earlier.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Emissary Capital Group, Inc. has initiated investment research coverage on Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) with a Buy rating and target price of $1.00-$1.25.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew J Mueting, DO 2501 Pierce St, Sioux City, IA 51104-3725 Ph: (712) 294-5000 | Andrew J Mueting, DO 2501 Pierce St, Sioux City, IA 51104-3725 Ph: (712) 294-5000 |
News Archive
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
A Tainan-based research team from National Cheng Kung University (NCKU) has discovered the pathogenesis of liver fibrosis and developed antibodies that reduce liver damage, inhibit hepatic fibrosis, and recover liver function.
Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. But a new diagnostic test developed by researchers at UC San Diego shows promise for detecting the disease earlier.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Emissary Capital Group, Inc. has initiated investment research coverage on Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) with a Buy rating and target price of $1.00-$1.25.
› Verified 2 days ago
Richard J. Kipp, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3520 Singing Hills Blvd, Sioux City, IA 51106 Phone: 712-294-7400 Fax: 712-294-7436 | |
Dylan C Greene, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1021 Nebraska St, Sioux City, IA 51105 Phone: 712-252-2477 Fax: 712-252-5920 | |
Kornelia Kellogg, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2501 Pierce St, Sioux City, IA 51104 Phone: 712-294-5000 Fax: 712-294-5092 | |
Michael John Jung, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2501 Pierce St, Sioux City, IA 51104 Phone: 712-294-5000 Fax: 712-294-5091 | |
Daniel Irwin, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2501 Pierce St, Sioux City, IA 51104 Phone: 712-294-5000 Fax: 712-294-5091 | |
Amjad Abdelhady, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2501 Pierce St, Sioux City, IA 51104 Phone: 712-294-5018 Fax: 712-294-5092 | |
Rodney L. Cassens, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Singing Hills Blvd, Ste 100, Sioux City, IA 51106 Phone: 712-274-4250 Fax: 712-274-4260 |